• Lab-Verified Research Peptides
Tesamorelin _ 10mg

Tesamorelin

$75.00 – $185.00

In stock

Buy Tesamorelin peptide at Velora Research — a synthetic GHRH analog supplied as a lyophilized research compound in 10mg vials. Each batch is independently HPLC- and mass-spec-verified at ≥99% purity, with a downloadable Certificate of Analysis tied to the lot number. Tesamorelin cost at Velora: $60 per 10mg vial, with free US shipping over $200. Strictly for in vitro laboratory research — not for human or veterinary use, and not the same product as EGRIFTA SV®.

Size
Pack Size
  • Purity: ≥99%
  • Form: Lyophilized Powder
  • Free shipping on orders $200+. 2-day US delivery.

Specifications

Purity
≥99%
Form
Lyophilized Powder
Storage
Store at -20°C

About Tesamorelin (research peptide supply)

Tesamorelin is a synthetic 44-amino-acid peptide analog of growth hormone-releasing hormone (GHRH 1-44), modified with an N-terminal trans-3-hexenoyl group that improves stability against enzymatic degradation. Velora Research supplies tesamorelin as a lyophilized research peptide for in vitro and preclinical investigation by qualified laboratories and research professionals.

Every Tesamorelin 10mg vial supplied by Velora is independently verified by a third-party analytical laboratory using high-performance liquid chromatography (HPLC) and mass spectrometry. The batch-specific Certificate of Analysis is published on our COAs page and linked from this product page so researchers can confirm identity, purity, and molecular integrity before placing the compound into a study.

How tesamorelin behaves in research models

Published research describes tesamorelin as a GHRH receptor agonist that, in preclinical and clinical models, binds pituitary somatotroph cells and stimulates endogenous growth hormone (GH) secretion in a pulsatile, physiologic pattern. Downstream, this is associated with elevations in insulin-like growth factor 1 (IGF-1).

  • Receptor target: GHRH receptor (GHRHR) on pituitary somatotrophs.
  • Class: GHRH analog — distinct from growth-hormone secretagogues such as ipamorelin, GHRP-2, and GHRP-6, which act on the ghrelin receptor.
  • Half-life: ~25–40 minutes in published clinical data, with sustained downstream effects on IGF-1.
  • Discovery and development: Originally developed by Theratechnologies. Tesamorelin acetate is the active ingredient in EGRIFTA SV®, an FDA-approved injectable for the reduction of excess abdominal visceral adipose tissue in HIV-infected patients with lipodystrophy.

EGRIFTA SV® is a registered trademark of Theratechnologies. Velora Research’s Tesamorelin product is a research peptide supplied for in vitro and preclinical investigation only and is not affiliated with, endorsed by, or equivalent to EGRIFTA SV®. It is not for human use.

Key specifications

Attribute Specification
Research name Tesamorelin (research peptide)
Chemical class Stabilized GHRH (1-44) analog
Sequence trans-3-hexenoyl-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2
Available size 10mg
Form Lyophilized white powder
Purity ≥99% (HPLC verified)
Molecular formula C221H366N72O67S
Molecular weight ~5135.87 g/mol
CAS number 218949-48-5
Storage (lyophilized) -20°C, sealed, dry, dark
Storage (reconstituted) 2-8°C, single-use aliquots recommended
Verification Independent third-party HPLC + mass spectrometry per batch
COA access Batch-specific COA at verify.janoshik.com (linked from this page)

Tesamorelin cost & availability

Velora Research lists Tesamorelin 10mg at a transparent, single-tier price so research buyers can plan procurement without negotiating per inquiry:

Vial size Tesamorelin cost (USD) Best for
10mg $60.00 Pilot studies, receptor-binding assays, single-protocol pilots, and most preclinical research designs

Tesamorelin cost can vary widely across research-peptide suppliers — from under $50 for vendors that don’t publish testing data, to several hundred dollars for clinical-grade Egrifta SV®. Velora’s $60 price reflects a research-grade compound that is independently HPLC- and mass-spec-verified at ≥99% purity, with a batch-specific COA accessible from the product page. Free US shipping applies on orders over $200, and most orders ship within 1–2 business days.

Why qualified researchers buy Tesamorelin from Velora Research

In a category where vendor quality varies dramatically, five things separate Velora Research from the field:

  • Batch-level third-party COA. Each lot of Tesamorelin peptide is verified by an independent analytical lab using HPLC for purity and mass spectrometry for identity; the COA is downloadable from the product page and tied to the batch number printed on the vial.
  • ≥99% HPLC-verified purity. Identity, purity, and molecular integrity confirmed before any batch is released for sale.
  • Documented production protocols. Lyophilized under controlled conditions, sealed in inert atmosphere, traceable from synthesis through shipment.
  • US-based 2-day shipping with cold-chain handling. Free over $200; orders processed within 1–2 business days.
  • Compliance-first sales policy. Sales restricted to qualified laboratories, institutions, and research professionals. Research-use-only terms acknowledged at checkout.

Reconstitution & storage guidance (research use)

Velora Research’s Tesamorelin ships as a lyophilized powder. For in vitro studies, researchers typically reconstitute with bacteriostatic water (0.9% benzyl alcohol) at a concentration matched to the assay protocol. A common pilot ratio for a 10mg vial is 2 mL of BAC water, yielding a 5 mg/mL stock solution — adjust per your study design.

  • Pre-reconstitution: store sealed at -20°C in a dry, dark environment. Avoid freeze-thaw cycles, which can degrade peptide integrity.
  • Post-reconstitution: refrigerate at 2-8°C and use within the stability window established by the study protocol. Single-use aliquots reduce the risk of repeat exposure to room temperature.
  • Handling: reconstitute and aliquot under sterile lab conditions with appropriate PPE.

Velora Research supplies bacteriostatic water as a separate product. Please refer to the peer-reviewed literature for protocol-specific reconstitution and handling parameters.

Tesamorelin vs. Sermorelin vs. Ipamorelin — research-context comparison

Researchers evaluating Tesamorelin for purchase often compare it to other growth-hormone-axis research peptides. Summary of how the three differ at the mechanism level, drawn from published research:

Attribute Tesamorelin Sermorelin Ipamorelin
Class Stabilized GHRH (1-44) analog Native GHRH fragment (1-29) Selective GHRP (ghrelin receptor)
Receptor target GHRH receptor GHRH receptor Ghrelin / GHS-R1a
Sequence length 44 amino acids 29 amino acids 5 amino acids
Half-life ~25–40 min ~10–20 min ~2 hours
FDA status (as of 2026) Approved as EGRIFTA SV® (HIV lipodystrophy) Not approved Not approved
Mechanism profile in research Sustained GHRH-receptor signaling Short-acting GHRH-receptor signaling Pulsatile, selective GH release without cortisol/prolactin spike

Figures are drawn from published preclinical and clinical literature and are provided strictly for research-context comparison. Velora Research’s Tesamorelin, Sermorelin, and Ipamorelin products are supplied as research peptides for in vitro and preclinical investigation only — not as therapeutic products.

Related products

Mots-c-main

MOTS-c

$64.99

10 MG

hcg-main

HCG

$69.99

5000 IU